--------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------------------------------------------------------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report: February 3, 2004
Date of Earliest Event Reported: February 3, 2004
MILLENNIUM CHEMICALS INC.
(Exact name of registrant as specified in its charter)
Delaware 1-12091 22-3436215
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer Identification Number)
incorporation or organization)
20 Wight Avenue, Suite 100
Hunt Valley, Maryland 21030
(Address of principal executive offices)
Registrant's telephone number, including area code: (410) 229-4400
Item 7. Financial Statements and Exhibits.
Exhibit Description
------- -----------
99.1 Press Release issued February 3, 2004
99.2 Investor Presentation made February 3, 2004
Item 9. Regulation FD Disclosure.
On February 3, 2004, Millennium Chemicals issued the press release
furnished as Exhibit 99.1 and then made the investor presentation furnished as
Exhibit 99.2 as part of its earnings release webcast. The foregoing press
release and investor presentation shall not be deemed to be "filed" for purposes
of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the
liabilities of that Section.
The information in this Current Report on Form 8-K shall not be
incorporated by reference into any registration statement or other document
filed pursuant to the Securities Act of 1933, as amended, except as shall be
expressly set forth by specific reference in such filing. Exhibits 99.1 and
99.2 contain certain "non-GAAP financial measures." The reasons for using
non-GAAP financial measures are explained on pages 3 and 4 of our Annual Report
on Form 10-K for the year ended December 31, 2002.
Item 12. This press release is being furnished pursuant to Item 9 and Item 12.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on behalf of the undersigned
hereunto duly authorized.
Dated: February 3, 2004 MILLENNIUM CHEMICALS INC.
By:/C. William Carmean/
----------------------------------------
C. William Carmean
Senior Vice President, General Counsel &
Secretary
EXHIBIT INDEX
Exhibit Description
------- -----------
99.1 Press release issued February 3, 2004
99.2 Investor presentation made February 3, 2004
STATEMENT OF DIFFERENCES
Characters normally expressed as subscript shall be preceded by............ [u]